Cytokinetics Inc (CYTK) Common Stock USD0.001
0.07%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$49.71
Buy:$49.76
Change:
$0.35
(0.71%)
$0.35
(0.71%)Market closed |
Prices delayed by at least 15 minutes
Sell:$49.71
Buy:$49.76
Change:$0.35
(0.71%)
$0.35
(0.71%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 September 2025 | Robert I BlumPresident/CEO | Sell Regular sell transaction (market) | 5,000 | $49.77 | $248,850.00 | 373,108 |
| 9 September 2025 | Fady Ibraham MalikExecutive Vice President | Sell Option/Award related | 2,000 | $51.29 | $102,580.00 | 140,610 |
| 2 September 2025 | Robert I BlumPresident/CEO | Sell Regular sell transaction (market) | 5,000 | $48.76 | $243,800.00 | 378,108 |
| 2 September 2025 | Edward M D KayeIndependent Director | Sell Regular sell transaction (market) | 6,756 | $50.00 | $337,800.00 | 23,230 |
| 2 September 2025 | Robert Arthur (Bob) HarringtonDirector | Sell Regular sell transaction (market) | 2,150 | $48.67 | $104,640.50 | 20,493 |
| 19 August 2025 | Fady Ibraham MalikExecutive Vice President | Sell Option/Award related | 2,000 | $38.31 | $76,620.00 | 140,610 |
| 15 August 2025 | Robert I BlumPresident/CEO | Sell Regular sell transaction (market) | 5,000 | $38.42 | $192,100.00 | 383,108 |
| 5 August 2025 | Fady Ibraham MalikExecutive Vice President | Sell Option/Award related | 2,000 | $36.34 | $72,680.00 | 140,610 |
| 29 July 2025 | Robert I BlumPresident/CEO | Sell Regular sell transaction (market) | 5,000 | $36.45 | $182,250.00 | 388,108 |
| 22 July 2025 | Fady Ibraham MalikExecutive Vice President | Sell Option/Award related | 2,000 | $37.47 | $74,940.00 | 140,610 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 March 2025 | Andrew CallosChief Level Officer | Sell Regular sell transaction (market) | 26,771 | $43.62 | $1,167,751.02 | 37,663 |
| 17 March 2025 | Robert I BlumPresident/CEO | Sell Regular sell transaction (market) | 25,000 | $44.65 | $1,116,250.00 | 339,181 |
| 5 March 2025 | Robert I BlumPresident/CEO | Sell Regular sell transaction (market) | 25,000 | $43.23 | $1,080,750.00 | 381,151 |
| 17 March 2025 | Andrew CallosChief Level Officer | Sell Option/Award related | 20,900 | $45.14 | $943,426.00 | 37,663 |
| 21 April 2025 | Wendell WierengaIndependent Director | Sell Option/Award related | 20,000 | $38.46 | $769,200.00 | 24,848 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.